Kalafati Lydia, Mitroulis Ioannis, Verginis Panayotis, Chavakis Triantafyllos, Kourtzelis Ioannis
Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
National Center for Tumor Diseases, Partner Site Dresden and German Cancer Research Center, Heidelberg, Germany.
Front Oncol. 2020 Dec 10;10:581457. doi: 10.3389/fonc.2020.581457. eCollection 2020.
Several lines of clinical and experimental evidence suggest that immune cell plasticity is a central player in tumorigenesis, tumor progression, and metastasis formation. Neutrophils are able to promote or inhibit tumor growth. Through their interaction with tumor cells or their crosstalk with other immune cell subsets in the tumor microenvironment, they modulate tumor cell survival. Here, we summarize current knowledge with regards to the mechanisms that underlie neutrophil-mediated effects on tumor establishment and metastasis development. We also discuss the tumor-mediated effects on granulopoiesis and neutrophil precursors in the bone marrow and the involvement of neutrophils in anti-tumor therapeutic modalities.
多条临床和实验证据表明,免疫细胞可塑性在肿瘤发生、肿瘤进展和转移形成过程中起着核心作用。中性粒细胞既能促进也能抑制肿瘤生长。通过与肿瘤细胞的相互作用或与肿瘤微环境中其他免疫细胞亚群的串扰,它们调节肿瘤细胞的存活。在此,我们总结了目前关于中性粒细胞介导肿瘤发生和转移发展作用机制的相关知识。我们还讨论了肿瘤对骨髓中粒细胞生成和中性粒细胞前体的影响以及中性粒细胞在抗肿瘤治疗方式中的作用。